SHARE
In Vitro Diagnostics Market 2020

In Vitro Diagnostics - Global Market Outlook (2018-2027)

4.7 (94 reviews)
Published: March 2020 ID: SMRC18977
4.7 (94 reviews)
Published: March 2020 ID: SMRC18977

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global In Vitro Diagnostics Market is accounted for $87.93 billion in 2018 and is expected to reach $164.40 billion by 2027 growing at a CAGR of 7.2% during the forecast period. Increasing adoption of fully automated instruments in labs, rising awareness on personalized medicine and consequent growth of chronic diseases are the major factors driving the market growth. However, adverse reimbursement scenario is restraining the market growth.

In Vitro Diagnostics (IVD) consists of medical devices and consumables that are utilized to detect any kind of infection and diseases by taking the specimen from the human body to cure diseases or its sequelae and perform in vitro tests on various biological samples. These products can be instruments, reagents, or any system used for the diagnosis of diseases. They are used for the diagnosis of various medical conditions, such as diabetes and cancer.

Based on end user, the point-of-care testing segment is likely to have a huge demand due to rising requirements of these testing’s as it includes biosensors, pregnancy kits and glucose meters to ensure quick and accurate results. By geography, North America is going to have a lucrative growth during the forecast period due to awareness among people regarding availability of innovative products and upsurge of strong prominent business players will lead to market growth.

Some of the key players profiled in the In Vitro Diagnostics Market include Abbott Laboratories Inc, Agilent Technologies, Becton Dickinson and Company, Biomérieux Sa, Bio-Rad Laboratories Inc, Cepheid, Danaher Corporation, Diasorin, Johnson & Johnson, Leica Biosystems Nussloch GmbH, Qiagen, Roche Diagnostics, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific.

Usability’s Covered:
• Reusable IVD Devices
• Disposable IVD Devices

Products Covered:
• Data Management Software
• Reagents & Kits
• Services
• Instruments   

Technologies Covered:
• Blood Testing
• Coagulation and Hemostasis
• Hematology
• Immunohematology
• Microbiology
• Tissue Diagnostics
• Urinalysis
• Clinical Chemistry
• Molecular Diagnostics
• Immunoassay/Immunochemistry

Applications Covered:
• Autoimmune Diseases
• Cardiology
• Diabetes
• Drug Testing/Pharmacogenomics
• Endocrinology
• Gastrointestinal Diseases
• HIV/Aids
• Infectious Diseases
• Nephrology
• Non Infectious Diseases
• Oncology   

End Users Covered:
• Academic Institutes
• Home Care
• Hospitals
• Patient Self-Testing
• Point-Of-Care Testing
• Laboratories

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary     
       
2 Preface      

 2.1 Abstract     
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology   
  2.4.1 Data Mining    
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions   
       
3 Market Trend Analysis    
 3.1 Introduction    
 3.2 Drivers     
 3.3 Restraints    
 3.4 Opportunities    
 3.5 Threats     
 3.6 Product Analysis    
 3.7 Technology Analysis   
 3.8 Application Analysis   
 3.9 End User Analysis    
 3.10 Emerging Markets    
 3.11 Impact of Covid-19   
       
4 Porters Five Force Analysis    

 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes   
 4.4 Threat of new entrants   
 4.5 Competitive rivalry    
       
5 Global In Vitro Diagnostics Market, By Usability  
 5.1 Introduction    
 5.2 Reusable IVD Devices   
 5.3 Disposable IVD Devices   
       
6 Global In Vitro Diagnostics Market, By Product  
 6.1 Introduction    
 6.2 Data Management Software   
 6.3 Reagents & Kits    
 6.4 Services     
 6.5 Instruments    
  6.5.1 Semi-Automated Instruments  
  6.5.2 Fully Automated Instruments  
       
7 Global In Vitro Diagnostics Market, By Technology  

 7.1 Introduction    
 7.2 Blood Testing    
 7.3 Coagulation and Hemostasis   
 7.4 Hematology    
 7.5 Immunohematology   
 7.6 Microbiology    
 7.7 Tissue Diagnostics    
 7.8 Urinalysis    
 7.9 Clinical Chemistry    
  7.9.1 Basic Metabolic Panel  
  7.9.2 Electrolyte Panel   
  7.9.3 Lipid Profile   
  7.9.4 Liver Panel   
  7.9.5 Renal Profile   
  7.9.6 Specialty Chemical Tests  
  7.9.7 Thyroid Function Panel  
 7.10 Molecular Diagnostics   
  7.10.1 Dna Sequencing & Next-Generation Sequencing
  7.10.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
  7.10.3 Microarray   
  7.10.4 Polymerase Chain Reaction (PCR) 
  7.10.5 Hybridization   
   7.10.5.1 In-Situ Hybridization 
   7.10.5.2 Fluorescence In-Situ Hybridization
 7.11 Immunoassay/Immunochemistry  
  7.11.1 Enzyme-Linked Immunospot Assays 
  7.11.2 Radioimmunoassay   
  7.11.3 Rapid Test   
  7.11.4 Western Blotting   
  7.11.5 Enzyme-Linked Immunosorbent Assay 
   7.11.5.1 Chemiluminescence Immunoassays
   7.11.5.2 Colorimetric Immunoassays 
   7.11.5.3 Fluorescence Immunoassays 
       
8 Global In Vitro Diagnostics Market, By Application  
 8.1 Introduction    
 8.2 Autoimmune Diseases   
 8.3 Cardiology    
 8.4 Diabetes     
 8.5 Drug Testing/Pharmacogenomics  
 8.6 Endocrinology    
 8.7 Gastrointestinal Diseases   
 8.8 HIV/Aids     
 8.9 Infectious Diseases    
 8.10 Nephrology    
 8.11 Non Infectious Diseases   
 8.12 Oncology     
       
9 Global In Vitro Diagnostics Market, By End User  
 9.1 Introduction    
 9.2 Academic Institutes    
 9.3 Home Care    
 9.4 Hospitals     
 9.5 Patient Self-Testing    
 9.6 Point-Of-Care Testing   
 9.7 Laboratories    
  9.7.1 Large/Reference Laboratories  
  9.7.2 Medium-Sized Laboratories  
  9.7.3 Small Laboratories   
       
10 Global In Vitro Diagnostics Market, By Geography  

 10.1 Introduction    
 10.2 North America    
  10.2.1 US    
  10.2.2 Canada    
  10.2.3 Mexico    
 10.3 Europe     
  10.3.1 Germany    
  10.3.2 UK    
  10.3.3 Italy    
  10.3.4 France    
  10.3.5 Spain    
  10.3.6 Rest of Europe   
 10.4 Asia Pacific    
  10.4.1 Japan    
  10.4.2 China    
  10.4.3 India    
  10.4.4 Australia    
  10.4.5 New Zealand   
  10.4.6 South Korea   
  10.4.7 Rest of Asia Pacific   
 10.5 South America    
  10.5.1 Argentina   
  10.5.2 Brazil    
  10.5.3 Chile    
  10.5.4 Rest of South America  
 10.6 Middle East & Africa   
  10.6.1 Saudi Arabia   
  10.6.2 UAE    
  10.6.3 Qatar    
  10.6.4 South Africa   
  10.6.5 Rest of Middle East & Africa  
       
11 Key Developments     
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
 11.2 Acquisitions & Mergers   
 11.3 New Product Launch   
 11.4 Expansions    
 11.5 Other Key Strategies   
       
12 Company Profiling     

 12.1 Abbott Laboratories Inc   
 12.2 Agilent Technologies   
 12.3 Becton Dickinson and Company  
 12.4 Biomérieux Sa    
 12.5 Bio-Rad Laboratories Inc   
 12.6 Cepheid     
 12.7 Danaher Corporation   
 12.8 Diasorin     
 12.9 Johnson & Johnson    
 12.10 Leica Biosystems Nussloch GmbH  
 12.11 Qiagen     
 12.12 Roche Diagnostics    
 12.13 Siemens AG    
 12.14 Sysmex Corporation   
 12.15 Thermo Fisher Scientific  


List of Tables      
1 Global In Vitro Diagnostics Market Outlook, By Region (2017-2027) ($MN)
2 Global In Vitro Diagnostics Market Outlook, By Usability (2017-2027) ($MN)
3 Global In Vitro Diagnostics Market Outlook, By Reusable IVD Devices (2017-2027) ($MN)
4 Global In Vitro Diagnostics Market Outlook, By Disposable IVD Devices (2017-2027) ($MN)
5 Global In Vitro Diagnostics Market Outlook, By Product (2017-2027) ($MN)
6 Global In Vitro Diagnostics Market Outlook, By Data Management Software (2017-2027) ($MN)
7 Global In Vitro Diagnostics Market Outlook, By Reagents & Kits (2017-2027) ($MN)
8 Global In Vitro Diagnostics Market Outlook, By Services (2017-2027) ($MN)
9 Global In Vitro Diagnostics Market Outlook, By Instruments (2017-2027) ($MN)
10 Global In Vitro Diagnostics Market Outlook, By Semi-Automated Instruments (2017-2027) ($MN)
11 Global In Vitro Diagnostics Market Outlook, By Fully Automated Instruments (2017-2027) ($MN)
12 Global In Vitro Diagnostics Market Outlook, By Technology (2017-2027) ($MN)
13 Global In Vitro Diagnostics Market Outlook, By Blood Testing (2017-2027) ($MN)
14 Global In Vitro Diagnostics Market Outlook, By Coagulation and Hemostasis (2017-2027) ($MN)
15 Global In Vitro Diagnostics Market Outlook, By Hematology (2017-2027) ($MN)
16 Global In Vitro Diagnostics Market Outlook, By Immunohematology (2017-2027) ($MN)
17 Global In Vitro Diagnostics Market Outlook, By Microbiology (2017-2027) ($MN)
18 Global In Vitro Diagnostics Market Outlook, By Tissue Diagnostics (2017-2027) ($MN)
19 Global In Vitro Diagnostics Market Outlook, By Urinalysis (2017-2027) ($MN)
20 Global In Vitro Diagnostics Market Outlook, By Clinical Chemistry (2017-2027) ($MN)
21 Global In Vitro Diagnostics Market Outlook, By Basic Metabolic Panel (2017-2027) ($MN)
22 Global In Vitro Diagnostics Market Outlook, By Electrolyte Panel (2017-2027) ($MN)
23 Global In Vitro Diagnostics Market Outlook, By Lipid Profile (2017-2027) ($MN)
24 Global In Vitro Diagnostics Market Outlook, By Liver Panel (2017-2027) ($MN)
25 Global In Vitro Diagnostics Market Outlook, By Renal Profile (2017-2027) ($MN)
26 Global In Vitro Diagnostics Market Outlook, By Specialty Chemical Tests (2017-2027) ($MN)
27 Global In Vitro Diagnostics Market Outlook, By Thyroid Function Panel (2017-2027) ($MN)
28 Global In Vitro Diagnostics Market Outlook, By Molecular Diagnostics (2017-2027) ($MN)
29 Global In Vitro Diagnostics Market Outlook, By Dna Sequencing & Next-Generation Sequencing (2017-2027) ($MN)
30 Global In Vitro Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2017-2027) ($MN)
31 Global In Vitro Diagnostics Market Outlook, By Microarray (2017-2027) ($MN)
32 Global In Vitro Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2017-2027) ($MN)
33 Global In Vitro Diagnostics Market Outlook, By Hybridization (2017-2027) ($MN)
34 Global In Vitro Diagnostics Market Outlook, By Immunoassay/Immunochemistry (2017-2027) ($MN)
35 Global In Vitro Diagnostics Market Outlook, By Enzyme-Linked Immunospot Assays (2017-2027) ($MN)
36 Global In Vitro Diagnostics Market Outlook, By Radioimmunoassay (2017-2027) ($MN)
37 Global In Vitro Diagnostics Market Outlook, By Rapid Test (2017-2027) ($MN)
38 Global In Vitro Diagnostics Market Outlook, By Western Blotting (2017-2027) ($MN)
39 Global In Vitro Diagnostics Market Outlook, By Enzyme-Linked Immunosorbent Assay (2017-2027) ($MN)
40 Global In Vitro Diagnostics Market Outlook, By Application (2017-2027) ($MN)
41 Global In Vitro Diagnostics Market Outlook, By Autoimmune Diseases (2017-2027) ($MN)
42 Global In Vitro Diagnostics Market Outlook, By Cardiology (2017-2027) ($MN)
43 Global In Vitro Diagnostics Market Outlook, By Diabetes (2017-2027) ($MN)
44 Global In Vitro Diagnostics Market Outlook, By Drug Testing/Pharmacogenomics (2017-2027) ($MN)
45 Global In Vitro Diagnostics Market Outlook, By Endocrinology (2017-2027) ($MN)
46 Global In Vitro Diagnostics Market Outlook, By Gastrointestinal Diseases (2017-2027) ($MN)
47 Global In Vitro Diagnostics Market Outlook, By HIV/Aids (2017-2027) ($MN)
48 Global In Vitro Diagnostics Market Outlook, By Infectious Diseases (2017-2027) ($MN)
49 Global In Vitro Diagnostics Market Outlook, By Nephrology (2017-2027) ($MN)
50 Global In Vitro Diagnostics Market Outlook, By Non Infectious Diseases (2017-2027) ($MN)
51 Global In Vitro Diagnostics Market Outlook, By Oncology (2017-2027) ($MN)
52 Global In Vitro Diagnostics Market Outlook, By End User (2017-2027) ($MN)
53 Global In Vitro Diagnostics Market Outlook, By Academic Institutes (2017-2027) ($MN)
54 Global In Vitro Diagnostics Market Outlook, By Home Care (2017-2027) ($MN)
55 Global In Vitro Diagnostics Market Outlook, By Hospitals (2017-2027) ($MN)
56 Global In Vitro Diagnostics Market Outlook, By Patient Self-Testing (2017-2027) ($MN)
57 Global In Vitro Diagnostics Market Outlook, By Point-Of-Care Testing (2017-2027) ($MN)
58 Global In Vitro Diagnostics Market Outlook, By Laboratories (2017-2027) ($MN)
59 Global In Vitro Diagnostics Market Outlook, By Large/Reference Laboratories (2017-2027) ($MN)
60 Global In Vitro Diagnostics Market Outlook, By Medium-Sized Laboratories (2017-2027) ($MN)
61 Global In Vitro Diagnostics Market Outlook, By Small Laboratories (2017-2027) ($MN)
       
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials